Objetivo
Since 1989, a new class of devices for R&D in immunology, diagnostics and pharmaceutical research has been sold to scientific and industrial laboratories called biospecific interaction analysis or affinity sensors. The first of these by a Swedish company is based on Surface Plasmon Resonance (SPR) and has growing importance in the biochemical laboratory. Other suppliers entered the market a little later. We have invented an improvement of the method. The prime proposing German SME has invented the improvement, and is at the moment filing a patent. First experiments and some theoretical calculations are completed. Another proposer is the Finnish research organisation VTT lab in Tampere, that had completed a conventional SPR device for industrial uses. J. Sadowski of VTT is an expert in SPR optics and applications. The second SME proposer is Swiss CYTOS that will be an end user. CYTOS has invented substantial improvements in mammal cell culture and biotechnology processes. At the same time, CYTOS will provide biochemical knowledge for the coating of biosensor chips that will be used within the device. Our improvement will enable us to reach mass markets with devices like existing affinity sensors but at much lower production costs. This will open totally new markets in process control in biotechnology, self-monitoring of medical clients or environmental pollution detectors. We will test our improvement in a joint feasibility study of MINT and VTT in the exploratory phase of the project and complete an RTD proposal by all three proposers. In the RTD project, we want to build an improved optical device at the VTT lab, and develop user specific biosensor coatings with CYTOS. MINT will coordinate the two RTD projects and take part in both. A partner for exploitation and manufacturing of the optical device within the later RTD project is still searched. We expect a market opportunity of at least 4 MECU per annum for the biosensor chips which will be shared by CYTOS and by MINT, and of 200 devices sold in the first year after initial offering, which will be shared by the partner searched and by MINT.
Since 1989, a new class of devices for R&D in immunology, diagnostics and pharmaceutical research has been sold to scientific and industrial laboratories called biospecific interaction analysis or affinity sensors. The first of these by a Swedish company is based on Surface Plasmon Resonance (SPR) and has growing importance in the biochemical laboratory. Other suppliers entered the market a little later. We have invented an improvement of the method. The prime proposing German SME has invented the improvement, and is at the moment filing a patent. First experiments and some theoretical calculations are completed. Another proposer is the Finnish research organisation VTT lab in Tampere, that had completed a conventional SPR device for industrial uses. J. Sadowski of VTT is an expert in SPR optics and applications. The second SME proposer is Swiss CYTOS that will be an end user. CYTOS has invented substantial improvements in mammal cell culture and biotechnology processes. At the same time, CYTOS will provide biochemical knowledge for the coating of biosensor chips that will be used within the device. Our improvement will enable us to reach mass markets with devices like existing affinity sensors but at much lower production costs. This will open totally new markets in process control in biotechnology, self-monitoring of medical clients or environmental pollution detectors. We will test our improvement in a joint feasibility study of MINT and VTT in the exploratory phase of the project and complete an RTD proposal by all three proposers. In the RTD project, we want to build an improved optical device at the VTT lab, and develop user specific biosensor coatings with CYTOS. MINT will coordinate the two RTD projects and take part in both. A partner for exploitation and manufacturing of the optical device within the later RTD project is still searched. We expect a market opportunity of at least 4 MECU per annum for the biosensor chips which will be shared by CYTOS and by MINT, and of 200 devices sold in the first year after initial offering, which will be shared by the partner searched and by MINT.
Ámbito científico (EuroSciVoc)
- ingeniería y tecnología ingeniería eléctrica, ingeniería electrónica, ingeniería de la información ingeniería electrónica sensores biosensores
- ciencias naturales ciencias físicas física de la materia condensada cuasipartículas
- ingeniería y tecnología ingeniería de materiales recubrimiento y películas
- ciencias naturales ciencias biológicas zoología mamalogía
- ciencias naturales matemáticas matemáticas aplicadas modelo matemático
Programa(s)
Programas de financiación plurianuales que definen las prioridades de la UE en materia de investigación e innovación.
Programas de financiación plurianuales que definen las prioridades de la UE en materia de investigación e innovación.
Tema(s)
Las convocatorias de propuestas se dividen en temas. Un tema define una materia o área específica para la que los solicitantes pueden presentar propuestas. La descripción de un tema comprende su alcance específico y la repercusión prevista del proyecto financiado.
Las convocatorias de propuestas se dividen en temas. Un tema define una materia o área específica para la que los solicitantes pueden presentar propuestas. La descripción de un tema comprende su alcance específico y la repercusión prevista del proyecto financiado.
Convocatoria de propuestas
Procedimiento para invitar a los solicitantes a presentar propuestas de proyectos con el objetivo de obtener financiación de la UE.
Datos no disponibles
Procedimiento para invitar a los solicitantes a presentar propuestas de proyectos con el objetivo de obtener financiación de la UE.
Régimen de financiación
Régimen de financiación (o «Tipo de acción») dentro de un programa con características comunes. Especifica: el alcance de lo que se financia; el porcentaje de reembolso; los criterios específicos de evaluación para optar a la financiación; y el uso de formas simplificadas de costes como los importes a tanto alzado.
Régimen de financiación (o «Tipo de acción») dentro de un programa con características comunes. Especifica: el alcance de lo que se financia; el porcentaje de reembolso; los criterios específicos de evaluación para optar a la financiación; y el uso de formas simplificadas de costes como los importes a tanto alzado.
Coordinador
80807 München
Alemania
Los costes totales en que ha incurrido esta organización para participar en el proyecto, incluidos los costes directos e indirectos. Este importe es un subconjunto del presupuesto total del proyecto.